Curcumin-loaded nanostructured systems for treatment of leishmaniasis: a review

• Douglas Dourado,
• Thayse Silva Medeiros,
• Éverton do Nascimento Alencar,
• Edijane Matos Sales and
• Fábio Rocha Formiga

Beilstein J. Nanotechnol. 2024, 15, 37–50, doi:10.3762/bjnano.15.4

• synthesized curc-coated silver nanoparticles (curc-AgNPs) for the treatment of cutaneous leishmaniasis [124]. Curc-AgNPs presented a spherical shape, 32 nm of diameter, and a zeta potential of −19.8 mV. This nanoformulation prevented the in vitro growth of L. major promastigotes and inhibited their viability

Nanotechnological approaches in the treatment of schistosomiasis: an overview

• Lucas Carvalho,
• Michelle Sarcinelli and
• Beatriz Patrício

Beilstein J. Nanotechnol. 2024, 15, 13–25, doi:10.3762/bjnano.15.2

• ; nanoformulation; nanotechnology; neglected diseases; praziquantel; schistosoma; Introduction Schistosomiasis is a disease common in tropical countries caused by trematodes from the genus Schistosoma. More than 220 million people are affected by this disease, in addition to 800 million at risk of infection [1][2

• four weeks postinfection altered the drug release pattern in vitro, were more efficient in reducing worm burden and the amount of eggs in the gut than PZQ alone, and altered the oogram pattern with the predominant presence of dead eggs. In addition, the nanoformulation showed no relevant toxicity in in

• vitro and in vivo models. Finally, the author discusses the possibility that the nanoformulation could be used to treat cases of schistosomiasis in the brain due to its smaller size [40]. Nevertheless, it is noteworthy that oral administration of biodegradable nanoparticles, such as conventional

Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics

• Mamta Kumari,
• Amitabha Acharya and
• Praveen Thaggikuppe Krishnamurthy

Beilstein J. Nanotechnol. 2023, 14, 912–926, doi:10.3762/bjnano.14.75

• affects the targeting ability of the nanoformulation. In this review, we provide recent findings to highlight several antibody conjugation methods such as adsorption, covalent conjugation, and biotin–avidin interaction. This review also provides an overview of the many effects of the protein corona and

• nanoformulation provided site-specific delivery via receptor-mediated endocytosis and inhibited proliferation and metastasis in tumors that expressed a specific tumor antigen. The use of adaptor molecules to functionalize antibodies resulted in a highly stable conjugation with improved therapeutic efficacy [69

Recent progress in cancer cell membrane-based nanoparticles for biomedical applications

• Qixiong Lin,
• Yueyou Peng,
• Yanyan Wen,
• Xiaoqiong Li,
• Donglian Du,
• Weibin Dai,
• Wei Tian and
• Yanfeng Meng

Beilstein J. Nanotechnol. 2023, 14, 262–279, doi:10.3762/bjnano.14.24

• through minimal residual disease [65][66]. Cancer cell membrane-based NPs have shown unique advantages in the treatment of leukemia. Johnson et al. prepared AML cell membrane-coated NPs with an immunostimulatory adjuvant [59]. The nanoformulation could induce leukemia-associated antigen-specific T-cell

• cancer shows high application potential regarding PTT and PDT [110]. A CQ-loaded nanoformulation based on cancer cell membranes was designed for the treatment of oral squamous cell carcinoma by the Dai group [80]. After high accumulation in tumor tissue, the nanoformulation can be activated under 660 nm

• the ability to target tumor tissue and enable multimodal imaging was fabricated for more efficient diagnosis and treatment by the Shu group. The biomimetic nanoformulation utilized hollow mesoporous Prussian blue nanoparticles as the core, endowing it with photothermal conversion and photoacoustic

Orally administered docetaxel-loaded chitosan-decorated cationic PLGA nanoparticles for intestinal tumors: formulation, comprehensive in vitro characterization, and release kinetics

• Sedat Ünal,
• Osman Doğan and
• Yeşim Aktaş

Beilstein J. Nanotechnol. 2022, 13, 1393–1407, doi:10.3762/bjnano.13.115

• studies on the Caco-2 cell line, the CS/DCX-PLGA formulation increased permeability by 383% compared to free DCX (p < 0.05). In the light of all results, CS/DCX-PLGA NPs can offer a promising and innovative approach as an oral anticancer drug-loaded nanoformulation for intestinal tumors. Keywords

• its polymeric protective structure, with the help of some modifications such as surface modifications, it allows the nanoformulation to exhibit locally higher concentrations in the colon [13][14][16][17][18]. Physiologically specific factors in the tumor microenvironment, such as increased negatively

Antibacterial activity of a berberine nanoformulation

• Hue Thi Nguyen,
• Tuyet Nhung Pham,
• Anh-Tuan Le,
• Nguyen Thanh Thuy,
• Tran Quang Huy and
• Thuy Thi Thu Nguyen

Beilstein J. Nanotechnol. 2022, 13, 641–652, doi:10.3762/bjnano.13.56

• the preparation of berberine (BBR) in nanoformulation to enhance its solubility and increase its antibacterial effectiveness against hospital-acquired infections. BBR nanoparticles (BBR NPs) were formed by antisolvent precipitation (ASP) using glycerol as a safe organic solvent. UV–vis absorption

• 156 nm at a concentration of 2.0 mg/mL, measured by dynamic light scattering. After nanoformulation, the concentration of BBR NPs could reach up to 5.0 mg/mL, which is much higher than the saturation concentration without treatment. Results show a strongly enhanced antibacterial activity of BBR NPs

• delivery efficiency of BBR. This nanoformulation increased the oral relative bioavailability to approximately 343% compared to that of the original BBR. Although nanoformulations have emerged as an effective approach to improve the bioavailability of BBR, several drawbacks should be addressed as follows

Ethosomal (−)-epigallocatechin-3-gallate as a novel approach to enhance antioxidant, anti-collagenase and anti-elastase effects

• Çiğdem Yücel,
• Gökçe Şeker Karatoprak,
• Sena Yalçıntaş and
• Tuğba Eren Böncü

Beilstein J. Nanotechnol. 2022, 13, 491–502, doi:10.3762/bjnano.13.41

• . It is seen that studies on its antiaging effectiveness are mostly done using plant extracts containing EGCG. Although it has been shown in the literature that it is promising to formulate EGCG by loading it into vesicular conduction systems for effective skin penetration, the nanoformulation and

Targeted therapeutic effect against the breast cancer cell line MCF-7 with a CuFe₂O₄/silica/cisplatin nanocomposite formulation

• B. Rabindran Jermy,
• Vijaya Ravinayagam,
• Widyan A. Alamoudi,
• Dana Almohazey,
• Hatim Dafalla,
• Lina Hussain Allehaibi,
• Abdulhadi Baykal,
• Muhammet S. Toprak and
• Thirunavukkarasu Somanathan

Beilstein J. Nanotechnol. 2019, 10, 2217–2228, doi:10.3762/bjnano.10.214

• and pore volume of 0.35 cm3/g. The cisplatin/CuFe2O4/HYPS nanoformulation showed the accumulation of copper ferrite nanoparticles on the surface and in the pores of HYPS with a surface area of 45 m2/g, pore size of 16 nm and pore volume of 0.18 cm3/g. Transmission electron microscopy (TEM) and energy

• -shell support thickness of about 50 nm was reported with a high ferrite loading capacity of about 30–50 wt % with particle diameters between 9 and 17 nm (at the external carbon layer). Such a magnetic nanoformulation was found to be useful for enzyme lysozyme immobilization. The magnetic properties of

• and CuFe2O4/silicalite. Characterization techniques Powder X-ray diffraction (PXRD) patterns for the CuFe2O4/HYPS nanoformulation were analyzed using a Miniflex 600 instrument (Rigaku, Japan). The surface textures the formulations were analyzed with a ASAP-2020 plus (Micromeritics, USA) instrument

Lipid nanostructures for antioxidant delivery: a comparative preformulation study

• Elisabetta Esposito,
• Maddalena Sguizzato,
• Markus Drechsler,
• Paolo Mariani,
• Federica Carducci,
• Claudio Nastruzzi,
• Giuseppe Valacchi and
• Rita Cortesi

Beilstein J. Nanotechnol. 2019, 10, 1789–1801, doi:10.3762/bjnano.10.174

• pretreatment with the nanoformulation resulted in significantly reduced heme oxygenase upregulation as compared to control samples, suggesting a protective effect provided by the nanoparticles. Keywords: α-tocopherol; cryogenic transmission electron microscopy (cryo-TEM); dermocosmetics; HO-1; nanostructured

The longstanding challenge of the nanocrystallization of 1,3,5-trinitroperhydro-1,3,5-triazine (RDX)

• Florent Pessina and
• Denis Spitzer

Beilstein J. Nanotechnol. 2017, 8, 452–466, doi:10.3762/bjnano.8.49

• sensitive than their macroscopic counterparts. When compared to pure RDX, the 90 wt % nanogels are not desensitized. However, small scale gap tests (SSGTs) preformed on pressed gels (95% TMD) revealed an improvement of the sensitivity for the 90 wt % RDX nanoformulation. The nanogel exhibits an uncommon

In vitro toxicity and bioimaging studies of gold nanorods formulations coated with biofunctional thiol-PEG molecules and Pluronic block copolymers

• Tianxun Gong,
• Douglas Goh,
• Malini Olivo and
• Ken-Tye Yong

Beilstein J. Nanotechnol. 2014, 5, 546–553, doi:10.3762/bjnano.5.64

• , colloidal, and structural properties of gold nanorods. We found that encapsulating gold nanorods with the thiolated PEG or PEO–PPO–PEO molecules guarantees the stability and biocompatibility of the nanoformulation. However, excessive use of these molecules during the passivation process leads to a reduction

• molecules significantly improved the colloidal and optical stability of the gold nanoformulation. No aggregation is found even a few weeks after the preparation. More importantly, the cell viability and dark-field imaging studies indicate that the AuNRs functionalized with PEG-SH or PEO–PPO–PEO molecules